In-article:

Cellectis: will present data against cancer – 06/10/2022 at 11:10


(CercleFinance.com) – Cellectis will present preclinical data on “smart” CAR T cells edited by TALEN allowing better targeting of solid tumors, at the annual meeting of the Society for Immunotherapy of Cancer (SITC) to be held in Boston from 8 to November 12, 2022.

Cellectis, which uses its pioneering TALEN genome-editing technology to develop innovative therapies for the treatment of serious diseases, today announced that preclinical data on TALEN-edited “smart” CAR T cells that can overcome key challenges targeting solid tumors.

On site, Cellectis will present several posters, including one on these “smart” CAR T cells and another on innovative T cell engineering strategies.



Source link -86